Categories U.S. Markets News

Pelosi in the lead for Speaker job as tech, healthcare stocks jump on midterm results

It was a bull run in the US market on Wednesday with the results of US midterm elections meeting expectations. Democrats won the House of Representatives, while Republicans strengthened their hold of the Senate, in what would turn out to be quite a situation in Washington.

The technology and healthcare stocks inched 1.5% higher on the news, as expectations of gridlocked government not being able to pass restrictions and related regulation came to the foreground.

Investors were quick to buy back into the market after the expected results, especially after a disastrous October.

An hour after the opening bell, Dow Jones Industrial Average was up 142.47 points, while the S&P 500 was up 21.30 points. The Nasdaq Composite gained 87.50 points.

After the October selloff, S&P 500 is still 5% below its all-time high. Other concerns regarding international foreign policy and trade war fears could be a few reasons for this.

Financial stocks, which where among the biggest gainers of the Trump administration, slipped 0.27% after bank stocks fell 0.52%.

 

Minority leader Nancy Pelosi (Left) meets with Kristin Davis, Goodwill Ambassador of UNHCR (SOURCE: Official Press)

The race for speaker

Many Democrats will soon be contesting for the top role in the House of Representatives, but 78-year-old San Francisco liberal Nancy Pelosi could be the first choice.

Minority leader Pelosi has already made it abundantly clear that she wants the job. She previously held the same position, that too as the first woman speaker, from 2007 to 2011.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top